629 related articles for article (PubMed ID: 22313023)
1. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
3. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
[TBL] [Abstract][Full Text] [Related]
4. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
[TBL] [Abstract][Full Text] [Related]
5. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
7. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
[TBL] [Abstract][Full Text] [Related]
9. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
[TBL] [Abstract][Full Text] [Related]
10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
11. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.
Filipcic I; Milovac Z; Sucic S; Gajsak T; Filipcic IS; Ivezic E; Aljinovic V; Orgulan I; Penic SZ; Bajic Z
Psychiatr Danub; 2017 Mar; 29(1):31-38. PubMed ID: 28291972
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
[TBL] [Abstract][Full Text] [Related]
15. An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context.
Godfrey KE; Muthukumaraswamy SD; Stinear CM; Hoeh NR
N Z Med J; 2019 Oct; 132(1504):46-55. PubMed ID: 31647794
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
[TBL] [Abstract][Full Text] [Related]
17. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
18. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
Ciobanu C; Girard M; Marin B; Labrunie A; Malauzat D
J Affect Disord; 2013 Sep; 150(2):677-81. PubMed ID: 23673085
[TBL] [Abstract][Full Text] [Related]
19. A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on.
Galletly CA; Clarke P; Carnell BL; Gill S
Aust N Z J Psychiatry; 2015 Nov; 49(11):1040-7. PubMed ID: 26508800
[TBL] [Abstract][Full Text] [Related]
20. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
